Methods of use of skin wound healing compositions
    1.
    发明申请
    Methods of use of skin wound healing compositions 有权
    使用皮肤伤口愈合组合物的方法

    公开(公告)号:US20120329719A1

    公开(公告)日:2012-12-27

    申请号:US13484162

    申请日:2012-05-30

    IPC分类号: A61K38/17 A61P17/02

    CPC分类号: C07K14/47 A61K38/00

    摘要: A wound healing composition comprising a class of polypeptide compounds having a polypeptide chain with 5 to 120 amino acid units per chain. The composition includes a pharmaceutical medium to carry the polypeptide compound, such as an aqueous solution, suspension, dispersion, salve, ointment, gel, cream, lotion, spray or paste. Additionally, a method of applying a wound healing composition comprising a class of polypeptide compounds having a polypeptide chain with 5 to 120 amino acid units per chain in a concentration of from about 1 μg/ml to about 100 μg/ml for a time sufficient to heal the wound is disclosed.

    摘要翻译: 一种伤口愈合组合物,其包含一类多肽化合物,所述多肽化合物具有每链5至120个氨基酸单元的多肽链。 组合物包括携带多肽化合物的药物介质,例如水溶液,悬浮液,分散体,药膏,软膏,凝胶,霜剂,洗剂,喷雾剂或糊剂。 另外,一种施用伤口愈合组合物的方法,其包含一类具有多肽链的多肽化合物,所述多肽化合物具有约1μg/ ml至约100μg/ ml浓度的每链5至120个氨基酸单元,时间足以 治愈伤口披露。

    Skin wound healing compositions and methods of use thereof
    2.
    发明授权
    Skin wound healing compositions and methods of use thereof 有权
    皮肤伤口愈合组合物及其使用方法

    公开(公告)号:US08207118B2

    公开(公告)日:2012-06-26

    申请号:US12505361

    申请日:2009-07-17

    IPC分类号: A61K38/00 A61K45/00

    CPC分类号: C07K14/47 A61K38/00

    摘要: A wound healing composition comprising a class of polypeptide compounds having a polypeptide chain with 5 to 120 amino acid units per chain. The composition includes a pharmaceutical medium to carry the polypeptide compound, such as an aqueous solution, suspension, dispersion, salve, ointment, gel, cream, lotion, spray or paste. Additionally, a method of applying a wound healing composition comprising a class of polypeptide compounds having a polypeptide chain with 5 to 120 amino acid units per chain in a concentration of from about 1 μg/ml to about 100 μg/ml for a time sufficient to heal the wound is disclosed.

    摘要翻译: 一种伤口愈合组合物,其包含一类多肽化合物,所述多肽化合物具有每链5至120个氨基酸单元的多肽链。 组合物包括携带多肽化合物的药物介质,例如水溶液,悬浮液,分散体,药膏,软膏,凝胶,霜剂,洗剂,喷雾剂或糊剂。 另外,一种施用伤口愈合组合物的方法,其包含一类具有多肽链的多肽化合物,所述多肽化合物具有约1μg/ ml至约100μg/ ml浓度的每链5至120个氨基酸单元,时间足以 治愈伤口披露。

    SKIN WOUND HEALING COMPOSITIONS AND METHODS OF USE THEREOF
    3.
    发明申请
    SKIN WOUND HEALING COMPOSITIONS AND METHODS OF USE THEREOF 有权
    皮肤治疗组合物及其使用方法

    公开(公告)号:US20110082082A1

    公开(公告)日:2011-04-07

    申请号:US12505361

    申请日:2009-07-17

    CPC分类号: C07K14/47 A61K38/00

    摘要: A wound healing composition comprising a class of polypeptide compounds having a polypeptide chain with 5 to 120 amino acid units per chain. The composition includes a pharmaceutical medium to carry the polypeptide compound, such as an aqueous solution, suspension, dispersion, salve, ointment, gel, cream, lotion, spray or paste. Additionally, a method of applying a wound healing composition comprising a class of polypeptide compounds having a polypeptide chain with 5 to 120 amino acid units per chain in a concentration of from about 1 pg/ml to about 100 μg/ml for a time sufficient to heal the wound is disclosed.

    摘要翻译: 一种伤口愈合组合物,其包含一类多肽化合物,所述多肽化合物具有每链5至120个氨基酸单元的多肽链。 组合物包括携带多肽化合物的药物介质,例如水溶液,悬浮液,分散体,药膏,软膏,凝胶,霜剂,洗剂,喷雾剂或糊剂。 另外,一种施用伤口愈合组合物的方法,其包含一类多肽化合物,所述多肽化合物具有多肽链,每个链具有约5至120个氨基酸单位,浓度为约1μg/ ml至约100μg/ ml,时间足以 治愈伤口披露。

    Methods of use of skin wound healing compositions
    4.
    发明授权
    Methods of use of skin wound healing compositions 有权
    使用皮肤伤口愈合组合物的方法

    公开(公告)号:US08455443B2

    公开(公告)日:2013-06-04

    申请号:US13484162

    申请日:2012-05-30

    IPC分类号: A61K38/00 A61K45/00

    CPC分类号: C07K14/47 A61K38/00

    摘要: A wound healing composition comprising a class of polypeptide compounds having a polypeptide chain with 5 to 120 amino acid units per chain. The composition includes a pharmaceutical medium to carry the polypeptide compound, such as an aqueous solution, suspension, dispersion, salve, ointment, gel, cream, lotion, spray or paste. Additionally, a method of applying a wound healing composition comprising a class of polypeptide compounds having a polypeptide chain with 5 to 120 amino acid units per chain in a concentration of from about 1 μg/ml to about 100 μg/ml for a time sufficient to heal the wound is disclosed.

    摘要翻译: 一种伤口愈合组合物,其包含一类多肽化合物,所述多肽化合物具有每链5至120个氨基酸单元的多肽链。 组合物包括携带多肽化合物的药物介质,例如水溶液,悬浮液,分散体,药膏,软膏,凝胶,霜剂,洗剂,喷雾剂或糊剂。 另外,一种施用伤口愈合组合物的方法,所述伤口愈合组合物包含一类多肽化合物,所述多肽化合物具有多肽链,每个链具有5至120个氨基酸单位,浓度为约1mug / ml至约100mug / ml,持续足够的时间 治愈伤口披露。

    SKIN WOUND HEALING COMPOSITIONS AND METHODS OF USE THEREOF
    6.
    发明申请
    SKIN WOUND HEALING COMPOSITIONS AND METHODS OF USE THEREOF 有权
    皮肤治疗组合物及其使用方法

    公开(公告)号:US20100035815A1

    公开(公告)日:2010-02-11

    申请号:US12522446

    申请日:2008-01-08

    IPC分类号: A61K38/17 A61P17/02

    摘要: A wound healing composition comprising an amount of heat shock protein effective to promote wound healing and a method thereof to apply the composition. A preferred heat shock protein is either full-length hsp90α or the middle domain plus the charged sequence of hsp90α. The composition is topically applied to skin wounds, covering the outer surface of the wound. The heat shock protein acts by promoting migration of both human epidermal keratinocyte and dermal fibroblasts to the wound in order to close, heal, and remodel the wound.

    摘要翻译: 一种伤口愈合组合物,其包含一定量的有效促进伤口愈合的热休克蛋白及其施用该组合物的方法。 优选的热休克蛋白是全长hsp90α或中间结构域加上hsp90α的带电序列。 组合物局部施用于皮肤伤口,覆盖伤口的外表面。 热休克蛋白通过促进人类表皮角质形成细胞和真皮成纤维细胞迁移到伤口来起作用,以关闭,愈合和改造伤口。

    Skin wound healing compositions and methods of use thereof
    7.
    发明授权
    Skin wound healing compositions and methods of use thereof 有权
    皮肤伤口愈合组合物及其使用方法

    公开(公告)号:US08410055B2

    公开(公告)日:2013-04-02

    申请号:US13210200

    申请日:2011-08-15

    IPC分类号: A61K38/00 A61K45/00 A61P43/00

    摘要: A wound healing composition comprising an amount of heat shock protein effective to promote wound healing and a method thereof to apply the composition. A preferred heat shock protein is either full-length hsp90α or the middle domain plus the charged sequence of hsp90α. The composition is topically applied to skin wounds, covering the outer surface of the wound. The heat shock protein acts by promoting migration of both human epidermal keratinocyte and dermal fibroblasts to the wound in order to close, heal, and remodel the wound.

    摘要翻译: 一种伤口愈合组合物,其包含一定量的有效促进伤口愈合的热休克蛋白及其施用该组合物的方法。 优选的热休克蛋白是全长hsp90α或中间结构域加上hsp90α的带电序列。 组合物局部施用于皮肤伤口,覆盖伤口的外表面。 热休克蛋白通过促进人类表皮角质形成细胞和真皮成纤维细胞迁移到伤口来起作用,以关闭,愈合和改造伤口。

    Skin wound healing compositions and methods of use thereof
    8.
    发明授权
    Skin wound healing compositions and methods of use thereof 有权
    皮肤伤口愈合组合物及其使用方法

    公开(公告)号:US08022037B2

    公开(公告)日:2011-09-20

    申请号:US12522446

    申请日:2008-01-08

    IPC分类号: A61K38/00 A61K45/00

    摘要: A wound healing composition comprising an amount of heat shock protein effective to promote wound healing and a method thereof to apply the composition. A preferred heat shock protein is either full-length hsp90α or the middle domain plus the charged sequence of hsp90α. The composition is topically applied to skin wounds, covering the outer surface of the wound. The heat shock protein acts by promoting migration of both human epidermal keratinocyte and dermal fibroblasts to the wound in order to close, heal, and remodel the wound.

    摘要翻译: 一种伤口愈合组合物,其包含一定量的有效促进伤口愈合的热休克蛋白及其施用该组合物的方法。 优选的热休克蛋白是全长hsp90α或中间结构域加上hsp90α的带电序列。 组合物局部施用于皮肤伤口,覆盖伤口的外表面。 热休克蛋白通过促进人类表皮角质形成细胞和真皮成纤维细胞迁移到伤口来起作用,以关闭,愈合和改造伤口。

    Method for promoting wound healing
    10.
    发明授权

    公开(公告)号:US10711052B2

    公开(公告)日:2020-07-14

    申请号:US13657594

    申请日:2012-10-22

    IPC分类号: A61K38/39 C07K14/78 A61K31/70

    摘要: The present invention discloses a method for treating wounds and for accelerating the healing of wounds by administering an effective amount of a pharmaceutical composition containing type VII collagen protein, mini-C7 protein, variants thereof or any combinations thereof. The pharmaceutical composition may be administered through a variety of routes including intravenous injection, topical application, or oral ingestion. The method may further include administering a genetically modified fibroblast capable of expressing type VII collagen protein, mini-C7 protein, variants thereof or small growth factors to achieve synergistic healing effect.